Lepu Biopharma Cancer Drug's NDA Approved by China's NDMA; Stocks Up 8%
Lepu Biopharma Cancer Drug's NDA Approved by China's NDMA; Stocks Up 8%
樂普生物癌症藥物的新藥上市申請獲得中國國家藥品監督管理局批准；股票上漲8%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間